Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,211,749
+$2,158,632 QoQ
Shares Held
29,928
+12.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#147
of 640 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $495,549,179 across 38 Biotechnology names. JAZZ ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
448,631 | $222,848,476 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
129,236 | $80,583,815 | |
| 3 | TECH |
BIO-TECHNE Corp
|
818,905 | $57,855,638 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
75,311 | $22,670,870 | |
| 5 | ARGX |
Argenx SE
|
19,088 | $17,709,273 | |
| 6 | INSM |
INSMED Inc
|
73,607 | $7,847,978 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
97,536 | $7,634,142 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
29,928 | $7,211,749 |
All Filings in JAZZ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,211,749 | 29,928 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $5,053,117 | 26,729 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $4,249,150 | 24,995 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $3,499,157 | 26,549 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $2,250,486 | 21,207 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,955,265 | 23,804 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $2,283,816 | 18,545 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $2,543,935 | 22,834 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $2,265,984 | 21,231 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $2,309,294 | 19,177 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $1,897,275 | 15,425 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $3,639,204 | 28,115 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $2,099,927 | 16,939 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $2,783,342 | 19,021 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $3,293,096 | 20,671 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $2,474,928 | 18,568 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $4,190,896 | 26,863 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $4,069,836 | 26,144 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $2,563,032 | 20,118 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $2,638,574 | 20,264 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $3,243,172 | 18,257 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $2,978,876 | 18,123 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $3,026,191 | 18,335 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $4,784,891 | 33,557 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $3,147,558 | 28,526 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $4,501,266 | 45,130 | Shares | Other | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||